Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026838 (
spasticity
)
6,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hypomyelinating leukodystrophies are a group of neurodevelopmental disorders that affect proper formation of the myelin sheath in the central nervous system. They are characterized by developmental delay, hypotonia,
spasticity
, and variable intellectual disability. We used whole exome analysis to study the molecular basis of hypomyelinating leukodystrophy in two sibs from a consanguineous family. A homozygous mutation, c.3068+5G>A, was identified in the
ATRN
gene, with the consequent insertion of an intronic sequence into the patients' cDNA and a predicted premature termination of the
ATRN
polypeptide.
ATRN
encodes
Attractin
, which was previously shown to play a critical role in central myelination. Several spontaneous
ATRN
rodent mutants exhibited impaired myelination which was attributed to oxidative stress and accelerated apoptosis.
ATRN
can now be added to the growing list of genes associated with hypomyelinating leukodystrophy. The disease seems to be confined to the CNS; however, given the young age of our patients, longer follow-up may be required.
...
PMID:Hypomyelinating leukodystrophy associated with a deleterious mutation in the ATRN gene. 2849 4